Clinical Trials Browser

Phase 1/2 × Completed × talimogene laherparepvec × Clear all

NCT02779855 2026-03-10

Talimogene Laherparepvec in Combination With Neoadjuvant Chemotherapy in Triple Negative Breast Cancer

Phase 1/2 Completed

50 enrolled 12 charts

Breast Neoplasms, Carcinoma, Ductal, Breast, Carcinoma, Ductal, Triple Negative Breast Neoplasms

NCT02509507 2024-08-06

MASTERKEY-318

Phase 1/2 Completed

127 enrolled 37 charts

Gastrointestinal

Carcinoma, Hepatocellular

NCT02453191 2024-06-20

TVEC and Preop Radiation for Sarcoma (4 ml Dose)

Phase 1/2 Completed

30 enrolled 12 charts

Sarcoma

NCT03555032 2021-08-18

TITAN

Phase 1/2 Completed

DermatologicSarcoma

Melanoma, Sarcoma